Response to: 'Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multi-center study' by Pregnalato et al

Ann Rheum Dis. 2019 Jun;78(6):e51. doi: 10.1136/annrheumdis-2018-213582. Epub 2018 May 5.

Authors

David S Pisetsky¹, Diane M Spencer¹, Peter E Lipsky², Brad H Rovin³

Affiliations

¹ Department of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, North Carolina, USA.
² RILITE Research Institute, Charlottesville, Virginia, USA.
³ Division of Nephrology, Department of Internal Medicine, Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.

PMID: 29730639
DOI: 10.1136/annrheumdis-2018-213582

No abstract available

Keywords: disease activity; rheumatoid arthritis; treatment.

Publication types

Letter
Comment

MeSH terms

Antibodies, Antinuclear
Arthritis, Rheumatoid*
Biological Assay
Humans
Immunologic Tests
Lupus Erythematosus, Systemic*

Substances

Antibodies, Antinuclear